With all the “measles outbreaks” that brought national headlines earlier this year, and resulted in many states introducing legislation to force vaccinate the public and remove vaccine exemptions for school-age children, one thing the national corporate-sponsored “mainstream” media failed to report, is that the only vaccine available in the U.S. for measles has been involved in an 9-year long legal battle for fraud, due to Merck’s own scientists who helped develop the vaccine becoming whistleblowers.
First of all, there is no measles vaccine available in the U.S., only a 3 dose combination vaccine for mumps, measles and rubella (MMR), which is licensed to Merck.
The mumps portion of the vaccine is what Merck’s own scientists have claimed is fraudulent, and not effective. The only time the corporate media, which is heavily funded by the pharmaceutical industry, really covered the lawsuit was two years after it was originally filed back in 2010, when in 2012 a judge unsealed key documents.
Here is a report Forbes wrote on it back in 2012. Some quotes:
Anyone who falls on either side of the debate about vaccines’ alleged potential to cause harm is sure to have heard the big news this week — the unsealing of a whistleblower suit against Merck, filed back in 2010 by two former employees accusing the drugmaker of overstating the effectiveness of its mumps, measles, and rubella vaccine.
The scientists claim Merck defrauded the U.S. government by causing it to purchase an estimated four million doses of mislabeled and misbranded MMR vaccine per year for at least a decade, and helped ignite two recent mumps outbreaks that the allegedly ineffective vaccine was intended to prevent in the first place.
“As the single largest purchaser of childhood vaccines (accounting for more than 50 percent of all vaccine purchasers), the United States is by far the largest financial victim of Merck’s fraud. But the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection against mumps. And while this is a disease the CDC targeted to eradicate by now, the failure in Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur,” the suit alleges. (Source – emphasis added.)
The Wall Street Journal also covered the story back in 2012, but according to a report by Dr. Mercola, the Wall Street Journal’s “elite” network of CFOs from the world’s top corporations met 3 days later (including executives from Merck), and the story was removed from their website.
It is not surprising then that the CDC and other government health agencies are concentrating on cases of measles in the U.S. public, instead of outbreaks of mumps which far exceeds measles outbreaks, and happens primarily among the vaccinated population.
Health Impact News has been following the Merck MMR fraud lawsuit for over 6 years now, and we exposed the hypocrisy of government health officials concentrating on measles outbreaks, even though mumps outbreaks are far more serious, earlier this year. See:
Why Aren’t Mumps Outbreaks Considered “Epidemic” When There are Thousands More Cases of Mumps than Measles?
MMR Vaccine Fraud: Why Aren’t Government Health Officials Talking About Mumps Outbreaks which Far Exceed Measles Outbreaks?
Attorney Robert F. Kennedy, Jr. is now reporting that the 9-year-old long MMR fraud lawsuit may be coming to an end, and that U.S. Department of Health and Human Services officials are trying to get the FDA to approve the Glaxo Smith Kline (GSK) version of the MMR vaccine in the U.S. in case the judge rules against Merck.
However, there is no evidence that GSK’s version of the vaccine is any better.
Merck Whistleblower Case Proceeds Toward a Resolution
by Robert F. Kennedy, Jr.
Children’s Health Defense
As the Merck MMR whistle blower case proceeds toward a resolution that increasingly appears to spell doom for Merck’s scandal ridden MMRII blockbuster, U.S. Department of Health and Human Services (DHHS) officials are scrambling to get Glaxo’s version of the MMR teed up to fill the coming vacuum.
Recap: Two senior Merck scientists, Stephen Krahling and Joan Wlochowski, filed their Federal whistleblower lawsuit in 2010 claiming Merck fraudulently added rabbit antibodies to human blood samples to gull FDA officials into believing the vaccine 95% effective and thereby win an MMR monopoly. When the scientists threatened to expose the fraud, Merck officials offered bribes, threatened them with prison and then destroyed the laboratory evidence in garbage bags.
Merck’s defective MMRII is currently causing dangerous Mumps epidemics in fully vaccinated adults across the globe. At FDA’s behest (GSK) recently published the results of US clinical trials for the hasty licensing of Glaxo’s (MMR) vaccine Priorix® (Klein et al. 2019). Knowing that no MMR can survive safety testing against an inert placebo, FDA allowed GSK to test Priorix against Merck’s MMR II. The results were so horrifying for both vaccine formulations that Glaxo and FDA decided against publishing them in the main paper burying them instead in a supplemental table within an addendum.
Table 6 displays the shocking results; Nearly 50% of vaccine recipients experienced adverse events within 42 days of vaccination and over 10% of these required emergency room visits. Roughly 2% of these adverse events were “serious” and 3.5% of vaccine recipients were diagnosed with a “new onset chronic disease” within 6 months of vaccination. These documented safety results are astronomically higher than the vaccine industry talking points which claim vaccine adverse events are “one-in-a-million”. They are much more in line with the results of the DHHS’s Lazarus study where 1 in 39 vaccine recipients showed an adverse reaction.
Read the full article at Children’s Health Defense
Comment on this article at VaccineImpact.com
© 2019 Children’s Health Defense, Inc.
This work is reproduced and distributed with the permission of Children’s Health Defense, Inc.